Billiet, Thomas <br/><br/>
Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn's disease.  [electronic resource] 

 -  Scandinavian journal of gastroenterology  Oct 2017 
 - 1086-1092 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1502-7708 
<br/><br/><label>Standard No.: </label>10.1080/00365521.2017.1339825  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies--blood<br/>Biomarkers--blood<br/>C-Reactive Protein--metabolism<br/>Crohn Disease--blood<br/>Cytokines--blood<br/>Female<br/>Gastrointestinal Agents--blood<br/>Humans<br/>Induction Chemotherapy<br/>Infliximab--blood<br/>Interferon-gamma--blood<br/>Interleukin-10--blood<br/>Interleukin-6--blood<br/>Interleukin-8--blood<br/>Male<br/>Middle Aged<br/>Serum Albumin--metabolism<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--blood